DOI:
10.1055/s-00000160
neuroreha
LinksClose Window
References
Fox RJ, Miller DH, Phillips JT. et al.
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.
N Engl J Med 2012;
367: 1087-1097
We do not assume any responsibility for the contents of the web pages of other providers.